People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Auxogyn Inc | — | Other Health Care | Series B | $73.1M | $327.3M | 2016 |
| Ribometrix, Inc. | — | Pharmaceuticals | Series A | $18.5M | $464.6M | 2018 |
Hakan Goker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hakan Goker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Beth Seidenberg | 1 | 15 |
| Joshua Resnick | 1 | 12 |
| Fred Cohen | 1 | 12 |
| Simeon George | 1 | 8 |
| Greg Garfield | 1 | 8 |
| Michael Solomon | 1 | 7 |
| William Marshall | 1 | 6 |
| Mark Gudiksen | 1 | 5 |
| Mark Weeks | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Michael Dial | 1 | 4 |
| Darrin Uecker | 1 | 3 |
| Edwin Neumann | 1 | 3 |
| Gina Bartasi | 1 | 3 |
| Kathy Harris | 1 | 3 |
| Linda Mintz | 1 | 3 |
| JOHN GUSTOFSON | 1 | 3 |
| Mike Dial | 1 | 2 |
| Laura Francis | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.